Skip to main content

Yorvipath Side Effects

Generic name: palopegteriparatide

Medically reviewed by Drugs.com. Last updated on Oct 10, 2024.

Note: This document provides detailed information about Yorvipath.

Applies to palopegteriparatide: parenteral prefilled injection pen Side Effects associated with palopegteriparatide. Some dosage forms listed on this page may not apply specifically to the brand name Yorvipath.

Applies to palopegteriparatide: parenteral prefilled injection pen.

Side effects include:

Most common adverse reactions (≥5%): injection site reactions, vasodilatory signs and symptoms, headache, diarrhea, back pain, hypercalcemia, oropharyngeal pain.

For healthcare professionals

Applies to palopegteriparatide: subcutaneous solution.

General adverse events

Adverse reactions occurring in at least 5% of patients included elevated albumin-corrected serum calcium, injection site reactions, vasodilatory signs and symptoms, headache, diarrhea, back pain, hypercalcemia, and oropharyngeal pain.[Ref]

Cardiovascular

Gastrointestinal

Hypersensitivity

Immunologic

Local

Metabolic

Musculoskeletal

Nervous system

Oncologic

Respiratory

See also:

References

1. (2024) "Product Information. Yorvipath Prefilled Pen (palopegteriparatide)." Ascendis Pharma, Inc.

Further information

Yorvipath side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.